Vanguard crLyme helps provide broad spectrum coverage against outer surface protein A (OspA), found in the tick, and contains antigens from multiple types of outer surface protein C (OspC), found in the tick and dog.
Indication: For vaccination of healthy dogs 8 weeks of age or older as an aid in prevention of clinical disease and subclinical arthritis associated with Borrelia burgdorferi.
- The first Lyme disease vaccine for dogs to contain a recombinant OspC protein
- Demonstrated efficacy in helping prevent Lyme infection
- Excellent performance in a field safety study
- Thimerosal free
- Covered by Companion Animal Immunization Support Guarantee (ISG)